Estrogen-induced upregulation and 3′-UTR shortening of CDC6
暂无分享,去创建一个
[1] E. Levin,et al. Integration of the extranuclear and nuclear actions of estrogen. , 2005, Molecular endocrinology.
[2] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[3] David Haussler,et al. The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..
[4] D. Gautheret,et al. Conservation of alternative polyadenylation patterns in mammalian genes , 2006, BMC Genomics.
[5] V. Scaria,et al. MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic β-actin gene , 2008, Nucleic acids research.
[6] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[7] H. Rochefort,et al. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Rogers,et al. Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain , 1980, Cell.
[9] V. Beneš,et al. Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. , 2004, The EMBO journal.
[10] E. Wahle. A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation , 1991, Cell.
[11] Jeffrey Wilusz,et al. The highways and byways of mRNA decay , 2007, Nature Reviews Molecular Cell Biology.
[12] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[13] Joel S Parker,et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.
[14] D. Bartel,et al. Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.
[15] R. Sutherland,et al. Estrogen regulation of cell cycle progression in breast cancer cells 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[16] Donny D. Licatalosi,et al. RNA processing and its regulation: global insights into biological networks , 2010, Nature Reviews Genetics.
[17] Elizabeth C. Theil,et al. Multiple, Conserved Iron-responsive Elements in the 3′-Untranslated Region of Transferrin Receptor mRNA Enhance Binding of Iron Regulatory Protein 2* , 2002, The Journal of Biological Chemistry.
[18] M. Hengartner,et al. Analysis of C. elegans intestinal gene expression and polyadenylation by fluorescence-activated nuclei sorting and 3′-end-seq , 2012, Nucleic acids research.
[19] E. Yaman,et al. Unliganded estrogen receptor-alpha activates transcription of the mammary gland Na+/I- symporter gene. , 2006, Biochemical and biophysical research communications.
[20] James B. Brown,et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. , 2012, Cell reports.
[21] V. Jordan,et al. Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). , 2005, Breast disease.
[22] B. Tian,et al. Alternative mRNA Polyadenylation Can Potentially Affect Detection of Gene Expression by Affymetrix GeneChip® Arrays , 2006, Applied bioinformatics.
[23] Vladimir B. Bajic,et al. Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes , 2003, Nucleic Acids Res..
[24] Anindya Dutta,et al. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.
[25] L. Paillard,et al. AU-rich elements and associated factors: are there unifying principles? , 2006, Nucleic acids research.
[26] A. Kerstan,et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. , 1999, Immunity.
[27] C. Lutz,et al. Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression , 2011, Wiley interdisciplinary reviews. RNA.
[28] V. Beneš,et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.
[29] P. Sharp,et al. Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.
[30] B. Geiger,et al. Zebrafish cyclin D1 is differentially expressed during early embryogenesis. , 1995, Biochimica et biophysica acta.
[31] G. Barton,et al. Direct Sequencing of Arabidopsis thaliana RNA Reveals Patterns of Cleavage and Polyadenylation , 2012, Nature Structural &Molecular Biology.
[32] L. Drury,et al. Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] Jie Yu,et al. Two Estrogen Response Element Sequences Near the PCNA Gene Are Not Responsible for Its Estrogen-Enhanced Expression in MCF7 Cells , 2008, PloS one.
[34] B. Hardesty,et al. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. , 1971, The Journal of biological chemistry.
[35] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Katzenellenbogen,et al. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells , 1999, Molecular and Cellular Endocrinology.
[37] Maria Sjöberg,et al. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. , 2005, Molecular endocrinology.
[38] Bin Tian,et al. A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.
[39] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[40] J. Nevins,et al. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] V. Kim,et al. The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.
[42] David G Johnson,et al. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. , 2006, Current molecular medicine.
[43] R. Agami,et al. Tumorigenicity of the miR-17-92 cluster distilled. , 2010, Genes & development.
[44] M. Pfaffl,et al. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR , 2006, Biotechnology Letters.
[45] Denghui Xing,et al. Alternative polyadenylation: a mechanism maximizing transcriptome diversity in higher eukaryotes. , 2009, Plant signaling & behavior.
[46] R. Elkon,et al. E2F mediates enhanced alternative polyadenylation in proliferation , 2012, Genome Biology.
[47] William Ritchie,et al. Differential Repression of Alternative Transcripts: A Screen for miRNA Targets , 2006, PLoS Comput. Biol..
[48] S Audic,et al. Alternate polyadenylation in human mRNAs: a large-scale analysis by EST clustering. , 1998, Genome research.
[49] Michael Recce,et al. PolyA_DB: a database for mammalian mRNA polyadenylation , 2004, Nucleic Acids Res..
[50] Wenbin Ye,et al. The Effect of Central Loops in miRNA:MRE Duplexes on the Efficiency of miRNA-Mediated Gene Regulation , 2008, PloS one.
[51] Mark Gerstein,et al. A genomic analysis of RNA polymerase II modification and chromatin architecture related to 3' end RNA polyadenylation. , 2008, Genome research.
[52] Noah Spies,et al. Biased chromatin signatures around polyadenylation sites and exons. , 2009, Molecular cell.
[53] L. E. Faber,et al. Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells , 2001, Breast Cancer Research and Treatment.
[54] J. Méndez,et al. CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. , 2008, Carcinogenesis.
[55] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[56] Clifford A. Meyer,et al. Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.
[57] F. Gebauer,et al. Translational control by 3′-UTR-binding proteins , 2012, Briefings in functional genomics.
[58] D. Bartel,et al. Formation, Regulation and Evolution of Caenorhabditis elegans 3′UTRs , 2010, Nature.
[59] A. E. Erson,et al. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers , 2010, Mammalian Genome.
[60] Guoli Ji,et al. Genome-wide landscape of polyadenylation in Arabidopsis provides evidence for extensive alternative polyadenylation , 2011, Proceedings of the National Academy of Sciences.
[61] C. Klinge. miRNAs and estrogen action , 2012, Trends in Endocrinology & Metabolism.
[62] V. Jordan,et al. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. , 1992, Journal of the National Cancer Institute.
[63] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[64] E. Wahle,et al. Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-binding Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage and Polyadenylation Specificity Factor* , 2009, The Journal of Biological Chemistry.
[65] D. Henley,et al. Estrogens and cell-cycle regulation in breast cancer , 2001, Trends in Endocrinology & Metabolism.
[66] J. Gustafsson,et al. Estrogen receptor action. , 2002, Critical reviews in eukaryotic gene expression.
[67] Yang Zhou,et al. Effects of miR‐541 on neurite outgrowth during neuronal differentiation , 2011, Cell biochemistry and function.
[68] David R. Setzer,et al. Size heterogeneity in the 3′ end of dihydrofolate reductase messenger RNAs in mouse cells , 1980, Cell.
[69] Mathieu Lupien,et al. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. , 2008, Cancer research.
[70] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[71] P. Kapranov,et al. Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation , 2010, Cell.
[72] Ryan J. Wagner,et al. MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem Cells , 2009, Stem cells.
[73] D. Di Paola,et al. Comparative analysis of pre‐replication complex proteins in transformed and normal cells , 2012, Journal of cellular biochemistry.
[74] D. Agard,et al. Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[75] P. Chambon,et al. Structural and functional domains of the estrogen receptor. , 1986, Cold Spring Harbor symposia on quantitative biology.
[76] Tyson A. Clark,et al. Nova regulates brain-specific splicing to shape the synapse , 2005, Nature Genetics.
[77] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[78] H. Auer,et al. Expression Profiling Using Affymetrix GeneChip Microarrays. , 2009, Methods in molecular biology.
[79] S. Leivonen,et al. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. , 2011, Cancer research.
[80] Kristian Helin,et al. Cell Cycle-Regulated Expression of MammalianCDC6 Is Dependent on E2F , 1998, Molecular and Cellular Biology.
[81] Pieter J. De Bleser,et al. ConTra v2: a tool to identify transcription factor binding sites across species, update 2011 , 2011, Nucleic Acids Res..
[82] S. Baylin,et al. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.
[83] John H. White,et al. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.
[84] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[85] Y. Sheen,et al. Estrogen modulation of human breast cancer cell growth , 1997, Archives of pharmacal research.
[86] Shuta Tomida,et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.
[87] D Gautheret,et al. Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. , 2001, Genome research.
[88] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[89] S. Peltz,et al. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.
[90] R. Young,et al. Multiple polyadenylation sites in a mouse alpha-amylase gene. , 1981, Nucleic acids research.
[91] C. Y. Chen,et al. AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.
[92] B. Cullen,et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.
[93] C. Klinge. Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.
[94] Artemis G. Hatzigeorgiou,et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.
[95] M. Dowsett,et al. Combination therapy with aromatase inhibitors: the next era of breast cancer treatment? , 2006, British Journal of Cancer.
[96] Bin Tian,et al. A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence , 2010, The EMBO journal.
[97] H. Handa,et al. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3′-UTRs , 2006, Nucleic acids research.
[98] Dennis B. Troup,et al. NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..
[99] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[100] Adrian Wiestner,et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. , 2007, Blood.
[101] David Baltimore,et al. Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends , 1980, Cell.
[102] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[103] Chong-Jian Chen,et al. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. , 2011, Genome research.
[104] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[105] V. Beneš,et al. Transcriptional complexes engaged by apo‐estrogen receptor‐α isoforms have divergent outcomes , 2004 .
[106] Peter A. Jones,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.
[107] M. Hentze,et al. From cis-regulatory elements to complex RNPs and back. , 2012, Cold Spring Harbor perspectives in biology.
[108] Eric T. Wang,et al. Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.
[109] Thomas D. Schmittgen,et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. , 2007, Cancer cell.
[110] Ozlen Konu,et al. Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues. , 2009, Oncology research.
[111] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[112] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[113] George A. Calin,et al. A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.
[114] B. Tian,et al. Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development , 2009, Proceedings of the National Academy of Sciences.
[115] B. Meyers,et al. Transcriptome dynamics through alternative polyadenylation in developmental and environmental responses in plants revealed by deep sequencing. , 2011, Genome research.
[116] Margaret Gardiner-Garden,et al. Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer , 2008, PloS one.
[117] C. Lutz,et al. Alternative polyadenylation: a twist on mRNA 3' end formation. , 2008, ACS chemical biology.
[118] J. Yates,et al. Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.
[119] S. Vagner,et al. Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation , 2009, Nucleic acids research.
[120] P. Klatt,et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus , 2006, Nature.
[121] Tyson A. Clark,et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing , 2008, Nature.
[122] Paolo Provero,et al. Shortening of 3′UTRs Correlates with Poor Prognosis in Breast and Lung Cancer , 2012, PloS one.
[123] J. Graber,et al. Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes. , 2009, Cancer research.
[124] Simion I. Chiosea,et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. , 2007, Cancer research.
[125] C. Brokamp,et al. Coordinated Post-transcriptional Regulation of Hsp70.3 Gene Expression by MicroRNA and Alternative Polyadenylation* , 2011, The Journal of Biological Chemistry.
[126] K. Bystricky,et al. Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression , 2010, PloS one.
[127] J. Thomsen,et al. Mechanisms of estrogen action. , 2001, Physiological reviews.
[128] S. Fuqua,et al. Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling , 2010, Clinical Cancer Research.
[129] B. Tian,et al. Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types , 2009, PloS one.
[130] A. E. Erson,et al. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. , 2009, Cancer genetics and cytogenetics.
[131] C. Mayr,et al. Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.
[132] E. Yaman,et al. Unliganded estrogen receptor-α activates transcription of the mammary gland Na+/I− symporter gene , 2006 .
[133] K. Nasmyth,et al. An essential role for the Cdc6 protein in forming the pre-replicative complexes of budding yeast , 1996, Nature.
[134] Simak Ali,et al. Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.
[135] J. Foekens,et al. Tamoxifen resistance in breast cancer: elucidating mechanisms. , 2001, Drugs.
[136] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.